XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.4
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (shares) at Apr. 30, 2019   11,619,538    
Beginning balance at Apr. 30, 2019 $ 2,238 $ 12 $ 72,924 $ (70,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 131   131  
Net income (641)     (641)
Ending balance (shares) at Jul. 31, 2019   11,619,538    
Ending balance at Jul. 31, 2019 1,728 $ 12 73,055 (71,339)
Beginning balance (shares) at Apr. 30, 2019   11,619,538    
Beginning balance at Apr. 30, 2019 2,238 $ 12 72,924 (70,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 72      
Ending balance (shares) at Jan. 31, 2020   11,823,274    
Ending balance at Jan. 31, 2020 3,177 $ 12 73,790 (70,625)
Beginning balance (shares) at Jul. 31, 2019   11,619,538    
Beginning balance at Jul. 31, 2019 1,728 $ 12 73,055 (71,339)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 77   77  
Issuance of common stock on exercise of stock options (in shares)   625    
Issuance of common stock on exercise of stock options and warrants 2   2  
Net income 307     307
Ending balance (shares) at Oct. 31, 2019   11,620,163    
Ending balance at Oct. 31, 2019 2,114 $ 12 73,134 (71,032)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 229   229  
Issuance of common stock on exercise of stock options (in shares)   203,111    
Issuance of common stock on exercise of stock options and warrants 427   427  
Net income 407     407
Ending balance (shares) at Jan. 31, 2020   11,823,274    
Ending balance at Jan. 31, 2020 3,177 $ 12 73,790 (70,625)
Beginning balance (shares) at Apr. 30, 2020   12,726,728    
Beginning balance at Apr. 30, 2020 5,318 $ 13 77,978 (72,673)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 120   120  
Issuance of common stock on exercise of stock options (in shares)   1,160    
Issuance of common stock on exercise of stock options and warrants 0      
Net income 75     75
Ending balance (shares) at Jul. 31, 2020   12,727,888    
Ending balance at Jul. 31, 2020 5,513 $ 13 78,098 (72,598)
Beginning balance (shares) at Apr. 30, 2020   12,726,728    
Beginning balance at Apr. 30, 2020 5,318 $ 13 77,978 (72,673)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 816      
Ending balance (shares) at Jan. 31, 2021   13,390,172    
Ending balance at Jan. 31, 2021 7,867 $ 13 79,711 (71,857)
Beginning balance (shares) at Jul. 31, 2020   12,727,888    
Beginning balance at Jul. 31, 2020 5,513 $ 13 78,098 (72,598)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 85   85  
Issuance of common stock on exercise of stock options (in shares)   640,657    
Issuance of common stock on exercise of stock options and warrants 1,294   1,294  
Net income 1     1
Ending balance (shares) at Oct. 31, 2020   13,368,545    
Ending balance at Oct. 31, 2020 6,893 $ 13 79,477 (72,597)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 232   232  
Issuance of common stock on exercise of stock options (in shares)   21,627    
Issuance of common stock on exercise of stock options and warrants 2   2  
Net income 740     740
Ending balance (shares) at Jan. 31, 2021   13,390,172    
Ending balance at Jan. 31, 2021 $ 7,867 $ 13 $ 79,711 $ (71,857)